Recent Changes in Federal Vaccine Recommendations: What’s the Impact on Insurance Coverage?
This policy watch provides an overview of recent changes to federal vaccine recommendations in the U.S. and what they mean for insurance coverage.
Read More
KFF Tracking Poll on Health Information and Trust: January 2025
As Senate hearings begin for President Trump’s health nominees, including Robert F. Kennedy Jr., the latest KFF Tracking Poll on Health Information and Trust shows a decline in public trust for government health agencies like the CDC, FDA, and local public health officials. The poll reveals growing skepticism about vaccines and school vaccine requirements, especially…
Why Are Aidoc’s AI Tools Winning Over Radiologists?
Clinical decision support startup Aidoc has become a major player in healthcare AI thanks to its focus on acute, life-or-death cases and its R&D-first approach. As Aidoc continues to innovate, Chief Business Officer Tom Valent thinks its commitment to patient safety and transparency will be key contributors to future success. The post Why Are Aidoc’s…
Es 2026 y no tienes seguro médico. ¿Y ahora qué?
Los cambios en las políticas de salud en Washington están teniendo repercusiones en todo el país y haciendo que millones de personas pierdan su cobertura de Medicaid o de la Ley de Cuidado de Salud a Bajo Precio (ACA). Pero todavía hay formas de acceder a la atención médica. Durante la próxima década, se espera…
Harris and Trump Are Ready To Take on Big Pharma
Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California’s attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United…
En Colorado, comienzan a usar hongos psicódelicos para experimentación terapéutica
BOULDER, Colorado — Los organismos reguladores de Colorado están emitiendo licencias que permiten suministrar hongos psicodélicos con fines terapéuticos. A fines de la primavera o principios del verano es posible que ya estén autorizados los primeros “centros de sanación” estatales, donde se podrán consumir los hongos bajo supervisión. Esto ocurre casi dos años después de…
Maybe It’s Not Just Aging. Maybe It’s Anemia.
Gary Sergott felt weary all the time. “I’d get tired, short of breath, a sort of malaise,” he said. He was cold even on warm days and looked pale with dark circles under his eyes. His malady was not mysterious. As a retired nurse anesthetist, Sergott knew he had anemia, a deficiency of red blood…
A Danish Couple’s Maverick African Research Finds Its Moment in RFK Jr.’s Vaccine Policy
In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe. Her supervisor, a fellow Dane named Peter Aaby, had spent nearly two decades collecting data on 100,000 people living in the mud brick homes of the West African country’s capital. Aaby and his partner, Christine Stabell Benn, believed that the…
Cohere Health Snags $90M to Automate the Much-Maligned Prior Authorization Process
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners. The post Cohere Health Snags $90M to Automate the Much-Maligned…
Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs
Novo Holdings led the Series A investment in Kivu Biosciences, developer of next-generation antibody drug conjugates for solid tumors. The startup’s ADCs and technology were licensed from Synaffix, a Lonza subsidiary. The post Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs appeared first on MedCity News.